BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nzerue C, Oluwole K, Adejorin D, Paueksakon P, Fremont R, Akatue R, Faulkner M. Malignant hypertension with thrombotic microangiopathy and persistent acute kidney injury (AKI). Clin Kidney J 2014;7:586-9. [PMID: 25503954 DOI: 10.1093/ckj/sfu116] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Haller H, Limbourg F, Schmidt B, Menne J. Seltene Formen der Hypertonie: Vom Phäochromozytom zur Vaskulitis. Internist 2015;56:255-62. [DOI: 10.1007/s00108-014-3571-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Hultström M, Becirovic-Agic M, Jönsson S. Comparison of acute kidney injury of different etiology reveals in-common mechanisms of tissue damage. Physiol Genomics 2018;50:127-41. [PMID: 29341864 DOI: 10.1152/physiolgenomics.00037.2017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
3 Berger BE. Atypical hemolytic uremic syndrome: a syndrome in need of clarity. Clin Kidney J 2019;12:338-47. [PMID: 31198222 DOI: 10.1093/ckj/sfy066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
4 Merino García E, Borrego Utiel FJ, Martínez Arcos MÁ, Borrego Hinojosa J, Pérez del Barrio MP. Kidney damage due to the use of anabolic androgenic steroids and practice of bodybuilding. Nefrología (English Edition) 2018;38:101-3. [DOI: 10.1016/j.nefroe.2017.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Hanna RM, Barsoum M, Vandross A, Kurtz I, Burwick R. Atypical hemolytic uremic syndrome and complement blockade: established and emerging uses of complement inhibition. Curr Opin Nephrol Hypertens 2019;28:278-87. [PMID: 30865166 DOI: 10.1097/MNH.0000000000000499] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Merino García E, Borrego Utiel FJ, Martínez Arcos MÁ, Borrego Hinojosa J, Pérez Del Barrio MP. Kidney damage due to the use of anabolic androgenic steroides and practice of bodybuilding. Nefrologia (Engl Ed) 2018;38:101-3. [PMID: 29325669 DOI: 10.1016/j.nefro.2017.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Huang H, Luo Y, Liang Y, Long X, Peng Y, Liu Z, Wen X, Jia M, Tian R, Bai C, Li C, He F, Lin Q, Wang X, Dong X. CD4(+)CD25(+) T Cells in primary malignant hypertension related kidney injury. Sci Rep 2016;6:27659. [PMID: 27278520 DOI: 10.1038/srep27659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Liang S, Le W, Liang D, Chen H, Xu F, Chen H, Liu Z, Zeng C. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study. BMC Nephrol 2016;17:42. [PMID: 27066888 DOI: 10.1186/s12882-016-0254-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
9 Cavero T, Arjona E, Soto K, Caravaca-fontán F, Rabasco C, Bravo L, de la Cerda F, Martín N, Blasco M, Ávila A, Huerta A, Cabello V, Jarque A, Alcázar C, Fulladosa X, Carbayo J, Anaya S, Cobelo C, Ramos N, Iglesias E, Baltar J, Martínez-gallardo R, Pérez L, Morales E, González R, Macía M, Draibe J, Pallardó L, Quintana LF, Espinosa M, Barros X, Pereira F, Cao M, Moreno JA, Rodríguez de Córdoba S, Praga M. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome. Kidney International 2019;96:995-1004. [DOI: 10.1016/j.kint.2019.05.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
10 Demiselle J, Beloncle F, Asfar P, Lerolle N. Hypertension artérielle maligne. Réanimation 2015;24:165-71. [DOI: 10.1007/s13546-015-1051-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Mathew RO, Nayer A, Asif A. The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy. J Am Soc Hypertens 2016;10:352-9. [PMID: 26778772 DOI: 10.1016/j.jash.2015.12.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]